|
A relationship-based approach to improving the clinical trial experience. |
| |
|
No Relationships to Disclose |
| |
|
|
Stock and Other Ownership Interests - Genentech |
| |
|
|
| |
|
|
Stock and Other Ownership Interests - Roche |
Travel, Accommodations, Expenses - Roche |
| |
|
|
Stock and Other Ownership Interests - Genentech |
| |
|
No Relationships to Disclose |
| |
|
Stock and Other Ownership Interests - Merck; United Health Group |
Travel, Accommodations, Expenses - Roche/Genentech |
| |
|
Employment - Sarah Cannon Research Institute |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Genentech |
| |
|
Travel, Accommodations, Expenses - Genentech/Roche |
Other Relationship - Genentech/Roche |
| |
|
No Relationships to Disclose |
| |
|
Travel, Accommodations, Expenses - Genentech; Roche |
| |
|
|
Stock and Other Ownership Interests - Genentech; Roche |
Consulting or Advisory Role - Genentech |
Travel, Accommodations, Expenses - Genentech |